Upcoming Articles of Recent Patents on CNS Drug Discovery:


Contents

Polyamine Modulation of NMDARs as a Mechanism to Reduce Effects of Alcohol Dependence
Susan Barron, Ben Lewis, Kristen Wellmann, Megan Carter, Justin Farook, Josh Ring, Dennis Trent Rogers, Robert Holley, Peter Crooks and John Littleton

Cholinergic Receptor System as a Target for Treating Alcohol Abuse and Dependence
Shafiqur Rahman and Mark A. Prendergast

Novel Medication Targets for the Treatment of Alcoholism: Preclinical Studies
Amir H. Rezvani, Andrew J. Lawrence, Maria P. Arolfo, Edward D. Levin and David H. Overstreet

The Development of Medications for Alcohol-Use Disorders Targeting the GABA_B Receptor System
Roberta Agabio, Paola Maccioni, Mauro A.M. Carai, Gian Luigi Gessa, Wolfgang Froestl and Giancarlo Colombo

Introduction to the Special Issue “Pharmacotherapies for the Treatment ofAlcohol Abuse and Dependence” and a Summary of Patents Targeting other Neurotransmitter Systems
Richard L. Bell, Kelle M. Franklin, Sheketha R. Hauser and Feng C. Zhou

The Nrf2-ARE pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Gururaj Joshi and Jeffrey A. Johnson

Curcuminoids in Neurodegenerative Diseases
Darrick S.H.L. Kim, Jin Y. Kim, and Ye-Sun Han

Immunocal® and Preservation of Glutathione as a Novel Neuroprotective Strategy for Degenerative Disorders of the Nervous System
Erika K. Ross, Josie J. Gray, Aimee N. Winter and Daniel A. Linseman

In the Rush for Green Gold: Can Green Tea Delay Age-Progressive Brain Neurodegeneration?
Silvia A Mandel and Moussa BH Youdim